Literature DB >> 8455602

Location of crossovers during gene targeting with insertion and replacement vectors.

C Deng1, K R Thomas, M R Capecchi.   

Abstract

Gene targeting was used to introduce nonselectable genetic changes into chromosomal loci in mouse embryo-derived stem cells. The nonselectable markers were linked to a selectable marker in both insertion- and replacement-type vectors, and the transfer of the two elements to the Hprt locus was assayed. When insertion vectors were used as substrates, the frequency of transfer was highly dependent upon the distance between the nonselectable marker and the double-strand break in the vector. A marker located close to the vector ends was frequently lost, suggesting that a double-strand gap repair activity is involved in vector integration. When replacement vectors were used, cotransfer of a selectable marker and a nonselectable marker 3 kb apart was over 50%, suggesting that recombination between vector and target often occurs near the ends of the vector. To illustrate the use of replacement vectors to transfer specific mutations to the genome, we describe targeting of the delta F508 mutation to the CFTR gene in mouse embryo-derived stem cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455602      PMCID: PMC359534          DOI: 10.1128/mcb.13.4.2134-2140.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  25 in total

1.  Extensive 3'-overhanging, single-stranded DNA associated with the meiosis-specific double-strand breaks at the ARG4 recombination initiation site.

Authors:  H Sun; D Treco; J W Szostak
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

Review 2.  Altering the genome by homologous recombination.

Authors:  M R Capecchi
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

3.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.

Authors:  K R Thomas; M R Capecchi
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

4.  PCR test for cystic fibrosis deletion.

Authors:  A Ballabio; R A Gibbs; C T Caskey
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

5.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

6.  Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells.

Authors:  P Hasty; R Ramírez-Solis; R Krumlauf; A Bradley
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

7.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 8.  The new mouse genetics: altering the genome by gene targeting.

Authors:  M R Capecchi
Journal:  Trends Genet       Date:  1989-03       Impact factor: 11.639

9.  Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells.

Authors:  V Valancius; O Smithies
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

10.  Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus.

Authors:  R Moore; G Casey; S Brookes; M Dixon; G Peters; C Dickson
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  30 in total

1.  Enrichment and efficient screening of ES cells containing a targeted mutation: the use of DT-A gene with the polyadenylation signal as a negative selection maker.

Authors:  Y Yanagawa; T Kobayashi; M Ohnishi; T Kobayashi; S Tamura; T Tsuzuki; M Sanbo; T Yagi; F Tashiro; J Miyazaki
Journal:  Transgenic Res       Date:  1999-06       Impact factor: 2.788

2.  The structure-specific endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic stem cells.

Authors:  L J Niedernhofer; J Essers; G Weeda; B Beverloo; J de Wit; M Muijtjens; H Odijk; J H Hoeijmakers; R Kanaar
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

3.  Mechanisms involved in targeted gene replacement in mammalian cells.

Authors:  J Li; M D Baker
Journal:  Genetics       Date:  2000-10       Impact factor: 4.562

4.  Incorporation of large heterologies into heteroduplex DNA during double-strand-break repair in mouse cells.

Authors:  Steven J Raynard; Mark D Baker
Journal:  Genetics       Date:  2002-10       Impact factor: 4.562

5.  Mechanisms of double-strand-break repair during gene targeting in mammalian cells.

Authors:  P Ng; M D Baker
Journal:  Genetics       Date:  1999-03       Impact factor: 4.562

6.  Targeted disruption of the Rad51 gene leads to lethality in embryonic mice.

Authors:  T Tsuzuki; Y Fujii; K Sakumi; Y Tominaga; K Nakao; M Sekiguchi; A Matsushiro; Y Yoshimura
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

7.  A novel possible mechanism for the genesis of genomic duplications and its experimental test.

Authors:  Moisés Mallo
Journal:  J Mol Evol       Date:  2005-07-28       Impact factor: 2.395

8.  Gene conversion during vector insertion in embryonic stem cells.

Authors:  P Hasty; J Rivera-Pérez; A Bradley
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

9.  Introduction of hereditary disease-associated mutations into the beta-amyloid precursor protein gene of mouse embryonic stem cells: a comparison of homologous recombination methods.

Authors:  M Gschwind; G Huber
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

10.  apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes.

Authors:  L S Huang; E Voyiaziakis; D F Markenson; K A Sokol; T Hayek; J L Breslow
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.